T cells take aim at cancer.
Pardoll
Drew
D
Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
D002465:Cell Movement; D002470:Cell Survival; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007167:Immunotherapy; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000494:pharmacology / Q000627:therapeutic use; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology / Q000637:transplantation; D008545:Melanoma / Q000276:immunology / Q000473:pathology / Q000628:therapy; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000637:transplantation; D016896:Treatment Outcome
D007376:Interleukin-2